Summary & Overview
CPT 94644: Inhalation Aerosol Treatment for Acute Airway Obstruction
CPT code 94644 represents administration of inhalation aerosol medication for up to one hour to treat acute airway obstruction. Nationally, this code captures a time-based, clinician-directed respiratory intervention commonly used in emergency and acute care settings to reverse bronchospasm, improve ventilation, and stabilize patients with obstructive respiratory events. It is important for claims accuracy and appropriate care documentation because it reflects direct therapeutic intervention in potentially life-threatening situations.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for use of the code, typical sites of service where it is billed, and insights into common billing considerations. The publication outlines benchmarks where available, summarizes relevant policy themes that affect coverage and reimbursement for acute inhalation therapies, and clarifies documentation elements that support appropriate coding. Data not available in the input will be explicitly noted where relevant. This summary is tailored for a national audience of coding professionals, clinicians, and policy analysts seeking a concise reference on CPT code 94644 and its role in acute respiratory care.
Billing Code Overview
CPT code 94644 describes the administration of an inhalation aerosol treatment with medication for up to one hour. The procedure is performed to treat acute airway obstruction and involves delivering aerosolized medication to relieve bronchospasm or other causes of compromised airway patency.
Service type: Inhalation therapy / aerosolized medication administration
Typical site of service: Emergency department or acute care setting, including hospital outpatient departments where urgent treatment for airway obstruction is provided.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department with acute bronchospasm and respiratory distress due to an exacerbation of asthma or chronic obstructive pulmonary disease (COPD). Vital signs show tachypnea, wheezing on auscultation, and hypoxia responsive to supplemental oxygen. The provider orders continuous inhalation aerosol therapy with bronchodilator medication delivered via nebulizer for up to one hour to relieve acute airway obstruction. Nursing documents medication, start and stop times, respiratory assessments at regular intervals, and response to therapy. If needed, repeat doses, adjunctive systemic steroids, or escalation to noninvasive ventilation are considered. The procedure is performed in an ED treatment area, urgent care, or inpatient respiratory therapy unit with direct provider oversight and appropriate monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service by the same physician on the same day of procedure | Use when a distinct evaluation and management visit is documented on the same day as 94644 (e.g., initial ED assessment leading to nebulizer therapy). |
52 |